Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all

​ Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss treatment long enough. Read More Breaking News, Latest News and Videos | CNN